ArticleScientific reports2026
Multimodal deep feature fusion with transformer for brain tumor classification from magnetic resonance imaging.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors (BTs) arise due to abnormal cell growth, which has a high mortality rate globally. Millions of lives can be saved through the timely identification of BT. Precise identification and segmentation of BTs are essential to enhance the precision of analysis and the efficiency of therapeutic strategies. Magnetic resonance imaging (MRI) is a broadly utilized analytical tool. Furthermore, deep learning (DL) has recently shown efficiency in addressing several computer vision tasks. Several DL-driven methods are implemented for BT segmentation and attained impressive outcomes. This study presents a Multimodal Deep Feature Fusion Framework for Automated Brain Tumor Detection and Segmentation (MDFF-ABTDS) model. This objective is to develop a multimodal DL that integrates feature fusion and transformer networks for the precise detection and segmentation of BTs from medical images. Initially, image pre-processing is performed using Contrast Limited Adaptive Histogram Equalization (CLAHE) and image normalization. Feature extraction is carried out through fusion models such as CapsNet, ResNet-50, and AlexNet. These extracted features are then passed to a bi-directional convolutional long short-term memory combined with transformer (TBConvL-Net) models to classify tumors and non-tumors effectively. Finally, the tumor is classified to identify its location using the nnUNet model for a precise segmentation process. A series of experimental analyses of the MDFF-ABTDS method portrayed a superior accuracy value of 98.91% over existing models under the BT MRI dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.